INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
The Perils in Managing mRNA Supply Chains. Get it Wrong, People Die—Part 2

The Perils in Managing mRNA Supply Chains. Get it Wrong, People Die—Part 2

This will blow your socks, pants and shirt off!!!

Hedley Rees's avatar
Hedley Rees
Jul 05, 2024
∙ Paid
16

Share this post

INSIDE PHARMA
INSIDE PHARMA
The Perils in Managing mRNA Supply Chains. Get it Wrong, People Die—Part 2
5
4
Share

This is Part 2

Part 1 of this post went out on July 3rd:

The Perils in Managing mRNA Supply Chains. Get it Wrong, People Die—Part 1

The Perils in Managing mRNA Supply Chains. Get it Wrong, People Die—Part 1

Hedley Rees
·
July 3, 2024
Read full story

I got the feeling that subscribers appreciated the unfettered explanation of this topic. That leads me to continue in a similar mode. At the end of the post, I said:

In Part 2, we will explore some of the more prominent companies that were part of the scam—prepare for a very big surprise…

…so here we go.

Glaxo, which became GSK, after multiple acquisitions of other big pharma companies

Based in Britain, former Glaxo chief, Sir Richard Sykes:

“As of June 2021, he is [was] chair of the UK's Vaccine Taskforce, where he is responsible for overseeing the delivery of the COVID-19 vaccination programme, including preparations for booster programmes and encouraging vaccine innovation in the UK.”

In 1994, during his time at Glaxo, he was part of the group that founded the Jenner Institute for research into vaccines. In 1995 he oversaw the merger of Glaxo with Wellcome, to form Glaxo-Wellcome. In 1997, he became chair of Glaxo-Wellcome. In 2000…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share